|
|
Botswana
|
BOT2404335
|
KRYXANA 200 MG
|
Microcrystalline Cellulose 67.44
|
NOVARTIS SINGAPORE PHARMACEUTICAL, Manufacturing PTY. LTD
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
A2400185
|
KRYXANA 200 MG
|
Microcrystalline Cellulose 67.44
|
NOVARTIS SINGAPORE PHARMACEUTICAL, Manufacturing PTY. LTD
|
Registered/Compliant
|
Details →
|
|
|
Zimbabwe
|
2023/9.7/6389
|
PAGENAX
|
BROLUCIZUMAB
|
NOVARTIS PHARMA STEIN AG, SCHAFFHAUSERSTRASSE , STEIN, SWITZERLAND; NOVARTIS OVERSEAS INVESTMENTS AG, LITCHTSTRASSE 35, BASEL, SWITZERLAND; LEK PHARMACEUTICALS D.D, VEROVSKOVA 57, LJUBLJANA, SLOVENIA; NOVARTIS PHARMACEUTICAL MANUFACTURING LLC, VEROVSKOVA ULICA , LJUBLJANA, SLOVENIA;
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
Details →
|
|
|
Zimbabwe
|
2018/9.2/5733
|
PATIZRA
|
RANIBIZUMAB
|
NOVARTIS PHARMA STEIN AG, SCHAFFHAUSERSTRASSE , STEIN, SWITZERLAND; NOVARTIS OVERSEAS INVESTMENTS AG, LITCHTSTRASSE 35, BASEL, SWITZERLAND; LEK PHARMACEUTICALS D.D, VEROVSKOVA 57, LJUBLJANA, SLOVENIA; NOVARTIS PHARMACEUTICAL MANUFACTURING LLC, VEROVSKOVA ULICA , LJUBLJANA, SLOVENIA;
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
Details →
|
|
|
Botswana
|
BOT2304094
|
PIVIKTO
|
-
|
NOVARTIS OVERSEAS INVESTMENTS AG
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
BOT2304094B
|
PIVIKTO
|
-
|
NOVARTIS OVERSEAS INVESTMENTS AG
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
BOT2304095B
|
PIVIKTO
|
-
|
NOVARTIS OVERSEAS INVESTMENTS AG
|
Registered/Compliant
|
Details →
|